Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Election Fraction

被引:28
|
作者
Regan, Jessica A. [1 ]
Kitzman, Dalane W. [2 ]
Leifer, Eric S. [3 ]
Kraus, William E. [1 ,7 ]
Fleg, Jerome L. [3 ]
Forman, Daniel E. [4 ,5 ]
Whellan, David J. [6 ]
Wojdyla, Daniel [7 ]
Parikh, Kishan [1 ,7 ]
O'Connor, Christopher M. [8 ]
Mentz, Robert J. [1 ,7 ]
机构
[1] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[2] Wake Forest Sch Med, Dept Internal Med, Sect Cardiovasc Med, Winston Salem, NC 27101 USA
[3] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[5] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[6] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA
[7] Duke Clin Res Inst, Durham, NC USA
[8] Inova Heart & Vasc Inst, Falls Church, VA USA
基金
美国国家卫生研究院;
关键词
age; body mass index; comorbidities; depression; heart failure with reduced ejection fraction; HF-ACTION; NONCARDIAC COMORBIDITIES; EJECTION FRACTION; OBESITY PARADOX; CO-MORBIDITIES; OLDER-ADULTS; DEPRESSION; MORTALITY; RISK; MULTIMORBIDITY;
D O I
10.1016/j.jchf.2019.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to determine whether age modifies the impact of key comorbidities on clinical outcomes for patients with heart failure with reduced ejection fraction (HFrEF). BACKGROUND Comorbidities impact outcomes in HFrEF. However, the effect of age on the impact of comorbidities on prognosis is not clearly understood. METHODS Cox proportional hazards models were used assessed interactions between age and comorbidities on the primary composite endpoint (all-cause mortality or hospitalization) and secondary endpoints in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) multicenter trial of 2,331 patients with HFrEF. RESULTS Age did not significantly modify the effect of any comorbidity on the primary endpoint. However, age significantly modified the effect of body mass index (BMI) on all-cause mortality (interaction p = 0.02). Among patients >= 70 years of age, there was a U-shaped relationship between BMI and 1-year mortality, where BMI of 20 kg/m(2) corresponded to 17.6%; a BMI of 30 kg/m(2) corresponded to 7.0%; and a BMI of 40 kg/m(2) corresponded to 11%. For patients <60 years of age, mortality increased nonsignificantly from 3.2% to 3.7% with increasing BMI. Age also modified the effect of depressive symptoms on alt-cause mortality (interaction p = 0.03). Among patients >= 70 years of age, a 1-year mortality rate significantly increased from 7.8% for a Beck Depression Inventory (BOO score of 5% to 15.6% for BIN of 20. For patients <60 years of age, mortality was nonsignificantly related to BDI. Cumulative comorbidity scores were stronger predictors than age for mortality/hospitalization. CONCLUSIONS hi chronic HFrEF, age markedly altered the impact of BMI and depressive symptoms on all-cause mortality, with much higher risk in older patients, but was not as strong a predictor of mortality/hospitalizations as cumulative comorbidity score. (C) 2019 by the American College of Cardiology Foundation.
引用
收藏
页码:1056 / 1065
页数:10
相关论文
共 50 条
  • [31] Outcomes in Patients With Heart Failure With Preserved Ejection Fraction It Is More Than the Heart
    Kitzman, Dalane W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (11) : 1006 - 1007
  • [32] Frailty and Its Implications in Heart Failure with Reduced Ejection Fraction Impact on Prognosis and Treatment
    Talha, Khawaja M.
    Greene, Stephen J.
    Butler, Javed
    Khan, Muhammad Shahzeb
    CARDIOLOGY CLINICS, 2023, 41 (04) : 525 - 536
  • [33] Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction
    Verheyen, Nicolas
    Schmid, Johannes
    Kolesnik, Ewald
    Schwegel, Nora
    Spaeth, Johannes
    Kattnig, Lydia
    Riepl, Hermann
    Zach, David
    Santner, Viktoria
    Hoeller, Viktoria
    Pilz, Stefan
    Tomaschitz, Andreas
    Fuchsjaeger, Michael
    Fahrleitner-Pammer, Astrid
    Dimai, Hans Peter
    Obermayer-Pietsch, Barbara
    Fruhwald, Friedrich
    Scherr, Daniel
    Zirlik, Andreas
    von Lewinski, Dirk
    Ablasser, Klemens
    ESC HEART FAILURE, 2024, 11 (03): : 1730 - 1738
  • [34] Obesity Paradox among Heart Failure with Reduced Ejection Fraction Patients: A Retrospective Cohort Study
    Alrob, Osama Abo
    Sankaralingam, Sowndramalingam
    Alazzam, Sayer
    Nusairat, Buthaina
    Qattoum, Muhammad
    Nusair, Mohammad B. B.
    MEDICINA-LITHUANIA, 2023, 59 (01):
  • [35] Impact of sacubitril/valsartan treatment on depression and anxiety in heart failure with reduced ejection fraction
    Dereli, Seckin
    Kilincel, Oguzhan
    Cerik, Idris Bugra
    Kaya, Ahmet
    ACTA CARDIOLOGICA, 2020, 75 (08) : 774 - 782
  • [36] Impact of Sleep Apnea, Daytime Sleepiness, Comorbidities, and Depression on Patients' Heart Failure Health Status
    Piamjariyakul, Ubolrat
    Shapiro, April L.
    Wang, Kesheng
    Zulfikar, Rafia
    Petitte, Trisha
    Shafique, Saima
    Smith, Carol E.
    CLINICAL NURSING RESEARCH, 2021, 30 (08) : 1222 - 1230
  • [37] The impact of preexisting comorbidities on failure to rescue outcomes in nonelderly trauma patients
    Bell, Teresa M.
    Zarzaur, Ben L.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2015, 78 (02) : 312 - 317
  • [38] Prognostic Impact of Non-Cardiac Comorbidities on Long-Term Prognosis in Patients with Reduced and Preserved Ejection Fraction following Acute Myocardial Infarction
    Savic, Lidija
    Mrdovic, Igor
    Asanin, Milika
    Stankovic, Sanja
    Lasica, Ratko
    Matic, Dragan
    Simic, Damjan
    Krljanac, Gordana
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (07):
  • [39] Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction
    Starr, Jessica A.
    Pinner, Nathan A.
    Lisenby, Katelin M.
    Osmonson, Alyssa
    PHARMACOTHERAPY, 2021, 41 (06): : 526 - 536
  • [40] Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry
    Constantinos Ergatoudes
    Maria Schaufelberger
    Bert Andersson
    Aldina Pivodic
    Ulf Dahlström
    Michael Fu
    Clinical Research in Cardiology, 2019, 108 : 1025 - 1033